“CLINICAL-PATOGENETIC RATIONALE FOR THE USE OF GLYCOSAMINOGLYCANS IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS”. Art of Medicine, vol. 28, no. 4, Dec. 2023, pp. 88-93, https://doi.org/10.21802/artm.2023.4.28.88.